SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-000146
Filing Date
2019-01-17
Accepted
2019-01-17 10:37:38
Documents
30
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-113018.htm 10-Q 165379
2 CERTIFICATION cannabics_10q-ex3101.htm EX-31.1 10083
3 CERTIFICATION cannabics_10q-ex3102.htm EX-31.2 10007
4 CERTIFICATION cannabics_10q-ex3201.htm EX-32.1 4826
5 CERTIFICATION cannabics_10q-ex3202.htm EX-32.2 4688
  Complete submission text file 0001683168-19-000146.txt   803484

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20180531.xml EX-101.INS 69662
7 XBRL SCHEMA FILE cnbx-20180531.xsd EX-101.SCH 9668
8 XBRL CALCULATION FILE cnbx-20180531_cal.xml EX-101.CAL 24182
9 XBRL DEFINITION FILE cnbx-20180531_def.xml EX-101.DEF 10587
10 XBRL LABEL FILE cnbx-20180531_lab.xml EX-101.LAB 82000
11 XBRL PRESENTATION FILE cnbx-20180531_pre.xml EX-101.PRE 58828
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 19530310
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1